| Keanan Foy, | |
|
459 N Main Street Suit 100, Bountiful, UT 84010 | |
| (801) 298-2000 | |
| Not Available |
| Full Name | Keanan Foy |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 459 N Main Street Suit 100, Bountiful, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992437412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Keanan Foy, 459 N Main Street Suit 100, Bountiful, UT 84010 Ph: () - | Keanan Foy, 459 N Main Street Suit 100, Bountiful, UT 84010 Ph: (801) 298-2000 |
News Archive
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Using magnetic nanoparticles labeled with dye molecules, a team of investigators at the Massachusetts General Hospital has developed a delivery vehicle capable of transporting antitumor small interfering RNA (siRNA) molecules into cells.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has purchased the ANDA for clindamycin phosphate (1%) and benzoyl peroxide (5%) gel from KV Pharmaceutical for $14 million in cash at closing and a $2 million milestone payment upon the completion of a successful technical transfer. This product is the AB-rated equivalent to Stiefel Laboratories' (a subsidiary of Glaxo SmithKline) Duac(R) gel, indicated for the topical treatment of inflammatory acne vulgaris.
Every time you make a memory, somewhere in your brain a tiny filament reaches out from one neuron and forms an electrochemical connection to a neighboring neuron.
› Verified 2 days ago
Bremen William Acord, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 415 Medical Dr Ste D101, Bountiful, UT 84010 Phone: 801-683-1062 Fax: 801-295-5537 | |
Ms. Jackie R Hawkins, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 956 E 800 S, Bountiful, UT 84010 Phone: 801-512-5756 | |
Brooke Kumar, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 70 N Main St Ste 104, Bountiful, UT 84010 Phone: 801-298-5222 | |
Holly Willard, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 201, Bountiful, UT 84010 Phone: 801-550-9057 | |
Suzanna Cressall, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 880 S 650 E, Bountiful, UT 84010 Phone: 801-318-9573 | |
Dr. Kelly Carl Feller, PHD, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 537 W 2600 S, Suite 203, Bountiful, UT 84010 Phone: 801-809-1049 | |
Penny Kay Allen, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1459 N Main St # 100, Bountiful, UT 84010 Phone: 801-298-2000 |